Emerging Stocks Down Under 5 January 2021: Zelira Therapeutics, Ecograf, IntelliHR

Emerging Stocks Down Under: Zelira Therapeutics, Ecograf, IntelliHR

Zelira Therapeutics: Awake to the insomnia opportunity

In today's edition of Emerging Stocks Down Under, if you can’t get to sleep because the market has gone against you, then take a look at the Perth-based Zelira Therapeutics. This medicinal cannabis company has insomnia as its lead indication, followed by a second major opportunity in autism. With cannabis stocks now back in favour, we believe this one will be getting high.

Also in today's edition, a look at graphite technology developer Ecograf (ASX: EGR) and HR system developer IntelliHR (ASX: IHR).

Get access to all editions through a 30-day FREE TRIAL. No credit card required and the trial expires automatically.

GET A 30-DAY FREE TRIAL

Click here to read the previous edition of Emerging Stocks Down Under published 29 December 2020

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter

Please register or upgrade your plan to access this content.

Save $$$
30-Day Free Trial
$0
No Credit Card Required!
Get access to 4 publications
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Profit Premium
$69
Get access to 4 publications
Access to the full research Archive
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
30-Day Free Trial
$0
No Credit Card Required!
Get access to 4 publications
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Profit Premium
$59
BILLED ANNUALLY
Get access to 4 publications
Access to the full research Archive
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks